Two single lung transplantations from one donor: lung twinning in the LAS era

Abstract

Objectives The implementation of the Lung Allocation Score (LAS) in the Eurotransplant international collaborative framework decreased waiting list mortality, but organ shortage remains a significant problem. Transplantation of two single lungs from one donor into two recipients (lung twinning) may decrease waiting list mortality. We sought to analyze if this strategy can lead to an acceptable intermediate-term outcome. Methods Since the LAS-implementation we performed 32 paired single-lung transplantations from 16 postmortal donors. Data and outcome were analyzed retrospectively comparing recipients receiving the first lung (first twins) with recipients receiving the second lung (second twins), left versus right transplantation and restrictive versus obstructive disease. Results Survival at one year was 81% and 54% at five years. Veno-venous ECMO had been successfully used as bridge-to-transplant in three patients with ECMO-explantation immediately after surgery. Bronchial anastomotic complications were not observed in any patient. First twins and second twins exhibited similar survival (p=0.82) despite higher LAS in first twins (median 45 versus 34, p<0.001) and longer cold ischemic time in second twins (280±83 vs. 478±125 min, p<0.001). Survival of left and right transplantation was similar (p=0.45) with similar best post-transplant FEV1 (68±15% versus 62±14%, p=0.26). Survival was similar in restrictive and obstructive disease (p=0.28) with better post-transplant FEV1 (70±15% versus 57±11%, p=0.02) in restrictive disease. Conclusions Performing two single-lung transplantations from one donor can be performed safely with encouraging intermediate-term outcome and good functional capacity. Lung twinning maximizes the donor pool and may help to overcome severe organ shortage. Clinical trials This research is not a clinical trial. Thus no registration details will be provided.